Th FDA granted another 510(k) clearance to iRhythm Technologies for its AI-powered software system designed for use with Verily’s irregular pulse tracking watch. The clearance is for an algorithm that categorizes patients’ AFib by analyzing how much of it they experience over time.
The pandemic has revealed many health inequities across society. A panel of speakers at MedCity News’ INVEST Pop Health conference discussed the various ways that they are working to reduce inequities and improve outcomes.
A new independent study from Phyx Primary Care’s Innovation Lab points to measurable improvements in physician burnout, documentation efficiency, and key VBC metrics among primary care practices.
Verily is being paid by iRhythm Technologies to develop a tool by improving existing hardware and software to effectively diagnose patients with asymptomatic atrial fibrillation.
Medical device company iRhythms Technologies last week filed for an $86 million initial public offering.
Cardiac rhythm diagnostics device maker iRhythm Technologies has raised $17 million, according to a company statement, as providers try to keep patients out of the hospital, but keep an eye on warning signs of worsening conditions. That trend will help drive the remote patient monitoring market to a projected $5.1 billion by 2020. Its ZIO […]